US88025U1097
US88025U1097
10x Genomics, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 10.51B EUR | 5B EUR | 2.74B EUR | 2.08B EUR |
Enterprise Value | 9.6B EUR | 4.57B EUR | 2.33B EUR | 1.69B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 1,051.91x | -- | -- | -- |
Price to Sales | 17.03x | 8.1x | 4.29x | 4.27x |
Price to Book | 12.73x | 6.05x | 3.36x | 2.62x |
EV/Revenue | 15.55x | 7.41x | 3.65x | 3.47x |
EV/EBITDA | -232.9x | 163x | 52.51x | 34.2x |
Price to FCF (P/FCF) | 58.49x | 41.13x | 22.41x | 21.33x |
EV/FCF | 53.41x | 37.64x | 19.07x | 17.34x |
FCF Yield | 1.71% | 2.43% | 4.46% | 4.69% |